tiprankstipranks
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
US Market
SNNAQ
Sienna Biopharmaceuticals
RESEARCH TOOLSreports

Sienna Biopharmaceuticals (SNNAQ) Financial Statements

71 Followers

Sienna Biopharmaceuticals Financial Overview

Sienna Biopharmaceuticals's market cap is currently $31.00. The company's EPS TTM is $-2; its P/E ratio is ―; Sienna Biopharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ -157.00K$ -120.00K
Operating Income$ -76.50M$ -48.57M
EBITDA$ -76.34M$ -48.45M
Net Income$ -73.31M$ -50.55M
Balance Sheet
Cash & Short-Term Investments$ 48.53M$ 74.47M
Total Assets$ 107.31M$ 136.85M
Total Debt$ 30.13M$ 0.00
Net Debt$ -18.40M$ -74.47M
Total Liabilities$ 80.72M$ 45.65M
Stockholders' Equity$ 159.37M$ 85.90M
Cash Flow
Free Cash Flow$ -61.73M$ -41.36M
Operating Cash Flow$ -61.69M$ -41.08M
Investing Cash Flow$ -39.00K$ -266.00K
Financing Cash Flow$ 35.96M$ 106.78M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

Income Statement >

Sienna Biopharmaceuticals Debt to Assets

Balance Sheet >

Sienna Biopharmaceuticals Cash Flow

Cash Flow >

Sienna Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >